Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion

被引:48
作者
Zeng, Qiqun [1 ,2 ]
Saghafinia, Sadegh [1 ,2 ]
Chryplewicz, Agnieszka [1 ,3 ]
Fournier, Nadine [4 ]
Christe, Lucine [5 ]
Xie, Yu-Qing [6 ]
Guillot, Jeremy [1 ,3 ]
Yucel, Simge [1 ,3 ]
Li, Pumin [1 ,3 ,7 ]
Galvan, Jose A. [5 ]
Karamitopoulou, Eva [5 ]
Zlobec, Inti [5 ]
Ataca, Dalya [2 ]
Gallean, Fleuriane [2 ]
Zhang, Peng [8 ]
Rodriguez-Calero, Jose Antonio [9 ]
Rubin, Mark [9 ]
Tichet, Melanie [1 ,3 ,10 ]
Homicsko, Krisztian [1 ,3 ,10 ,11 ,12 ]
Hanahan, Douglas [1 ,3 ,10 ,12 ]
机构
[1] Swiss Fed Inst Technol Lausanne EPFL, Swiss Inst Expt Canc Res ISREC, Sch Life Sci, CH-1015 Lausanne, Switzerland
[2] Opna Bio SA, Biopole, CH-1066 Epalinges, Switzerland
[3] Agora Canc Res Ctr, CH-1011 Lausanne, Switzerland
[4] Swiss Inst Bioinformat SIB, CH-1015 Lausanne, Switzerland
[5] Univ Bern, Inst Pathol, CH-3008 Bern, Switzerland
[6] Swiss Fed Inst Technol Lausanne EPFL, Inst Bioengn, Sch Engn, CH-1015 Lausanne, Switzerland
[7] Univ Lausanne, Dept Computat Biol, CH-1015 Lausanne, Switzerland
[8] Capital Med Univ, Beijing Pediat Res Inst, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Beijing 100045, Peoples R China
[9] Univ Bern, Dept BioMed Res, CH-3008 Bern, Switzerland
[10] Ludwig Inst Canc Res, Lausanne Branch, CH-1011 Lausanne, Switzerland
[11] Univ Hosp Lausanne CHUV, Dept Oncol, CH-1011 Lausanne, Switzerland
[12] Swiss Canc Ctr Leman SCCL, CH-1011 Lausanne, Switzerland
基金
瑞士国家科学基金会;
关键词
D O I
10.1126/science.abl7207
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Many human cancers manifest the capability to circumvent attack by the adaptive immune system. In this work, we identified a component of immune evasion that involves frequent up-regulation of fragile X mental retardation protein (FMRP) in solid tumors. FMRP represses immune attack, as revealed by cancer cells engineered to lack its expression. FMRP-deficient tumors were infiltrated by activated T cells that impaired tumor growth and enhanced survival in mice. Mechanistically, FMRP's immunosuppression was multifactorial, involving repression of the chemoattractant C-C motif chemokine ligand 7 (CCL7) concomitant with up-regulation of three immunomodulators-interleukin-33 (IL-33), tumor-secreted protein S (PROS1), and extracellular vesicles. Gene signatures associate FMRP's cancer network with poor prognosis and response to therapy in cancer patients. Collectively, FMRP is implicated as a regulator that orchestrates a multifaceted barrier to antitumor immune responses.
引用
收藏
页数:24
相关论文
共 85 条
[1]   scGate: marker-based purification of cell types from heterogeneous single-cell RNA-seq datasets [J].
Andreatta, Massimo ;
Berenstein, Ariel J. ;
Carmona, Santiago J. .
BIOINFORMATICS, 2022, 38 (09) :2642-2644
[2]   Interpretation of T cell states from single-cell transcriptomics data using reference atlases [J].
Andreatta, Massimo ;
Corria-Osorio, Jesus ;
Muller, Soren ;
Cubas, Rafael ;
Coukos, George ;
Carmona, Santiago J. .
NATURE COMMUNICATIONS, 2021, 12 (01)
[3]  
BAKKER CE, 1994, CELL, V78, P23
[4]   Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 [J].
Barbie, David A. ;
Tamayo, Pablo ;
Boehm, Jesse S. ;
Kim, So Young ;
Moody, Susan E. ;
Dunn, Ian F. ;
Schinzel, Anna C. ;
Sandy, Peter ;
Meylan, Etienne ;
Scholl, Claudia ;
Froehling, Stefan ;
Chan, Edmond M. ;
Sos, Martin L. ;
Michel, Kathrin ;
Mermel, Craig ;
Silver, Serena J. ;
Weir, Barbara A. ;
Reiling, Jan H. ;
Sheng, Qing ;
Gupta, Piyush B. ;
Wadlow, Raymond C. ;
Le, Hanh ;
Hoersch, Sebastian ;
Wittner, Ben S. ;
Ramaswamy, Sridhar ;
Livingston, David M. ;
Sabatini, David M. ;
Meyerson, Matthew ;
Thomas, Roman K. ;
Lander, Eric S. ;
Mesirov, Jill P. ;
Root, David E. ;
Gilliland, D. Gary ;
Jacks, Tyler ;
Hahn, William C. .
NATURE, 2009, 462 (7269) :108-U122
[5]  
Bayraktar Soley, 2019, J Carcinog, V18, P2, DOI 10.4103/jcar.JCar_2_19
[6]   Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer [J].
Brahmer, Julie R. ;
Tykodi, Scott S. ;
Chow, Laura Q. M. ;
Hwu, Wen-Jen ;
Topalian, Suzanne L. ;
Hwu, Patrick ;
Drake, Charles G. ;
Camacho, Luis H. ;
Kauh, John ;
Odunsi, Kunle ;
Pitot, Henry C. ;
Hamid, Omid ;
Bhatia, Shailender ;
Martins, Renato ;
Eaton, Keith ;
Chen, Shuming ;
Salay, Theresa M. ;
Alaparthy, Suresh ;
Grosso, Joseph F. ;
Korman, Alan J. ;
Parker, Susan M. ;
Agrawal, Shruti ;
Goldberg, Stacie M. ;
Pardoll, Drew M. ;
Gupta, Ashok ;
Wigginton, Jon M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2455-2465
[7]   Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma [J].
Castle, John C. ;
Loewer, Martin ;
Boegel, Sebastian ;
de Graaf, Jos ;
Bender, Christian ;
Tadmor, Arbel D. ;
Boisguerin, Valesca ;
Bukur, Thomas ;
Sorn, Patrick ;
Paret, Claudia ;
Diken, Mustafa ;
Kreiter, Sebastian ;
Tureci, Ozlem ;
Sahin, Ugur .
BMC GENOMICS, 2014, 15
[8]   Exosome-Mediated Crosstalk Between Tumor and Tumor-Associated Macrophages [J].
Chen, Qi ;
Li, Yuefeng ;
Gao, Wujiang ;
Chen, Lu ;
Xu, Wenlin ;
Zhu, Xiaolan .
FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
[9]   A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells [J].
Cheng, Sijin ;
Li, Ziyi ;
Gao, Ranran ;
Xing, Baocai ;
Gao, Yunong ;
Yang, Yu ;
Qin, Shishang ;
Zhang, Lei ;
Ouyang, Hanqiang ;
Du, Peng ;
Jiang, Liang ;
Zhang, Bin ;
Yang, Yue ;
Wang, Xiliang ;
Ren, Xianwen ;
Bei, Jin-Xin ;
Hu, Xueda ;
Bu, Zhaode ;
Ji, Jiafu ;
Zhang, Zemin .
CELL, 2021, 184 (03) :792-+
[10]   Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy [J].
Chow, Melvyn T. ;
Ozga, Aleksandra J. ;
Servis, Rachel L. ;
Frederick, Dennie T. ;
Lo, Jennifer A. ;
Fisher, David E. ;
Freeman, Gordon J. ;
Boland, Genevieve M. ;
Luster, Andrew D. .
IMMUNITY, 2019, 50 (06) :1498-+